Important Update: We want to inform you that, due to ongoing technical maintenance, our applications will be temporarily unavailable. Learn more here >>>

Redefining mental health care in oncology through digital innovation

To Our Solution
Guided by HIPAA and FDA regulations in the US
Class I medical device aligned with the European MDR 2017/745
Products designed and developed in accordance with ISO 13485 [Medical Device Quality Management System]
Following the highest standards in data security and protection (ISO/IEC 27001, EU GDPR)

Validated medical product

Living Well is the only self-care solution delivering psychological and behavioral support to cancer patients instantly, cost-effectively, and reliably.

Its clinically validated program, designed explicitly for cancer patients, reduces symptoms of stress, anxiety, and depression related to the diagnosis and treatment of cancer which improves patients' emotional functioning, quality of life, and overall outcomes.

Reach Out to Living Well
icon patient

Living Well


Find out more about what Living Well can do for you throughout your cancer journey.

Find out more
arrow icon
icon doctors

Living Well


Find out more about how Living Well can support your patients and the care you provide.

Find out more
arrow icon

Experts weigh in on Living Well

Cancer not only affects the body, but also the mind, so for patients to receive truly adequate care, it is necessary to add a psychological dimension to the care they are receiving.

Prof. Ewa Wojtyna, MD

I strongly believe that Living Well is innovative and supportive, and that it provides excellent opportunities for patients to manage their feelings and emotions and, thus, improve the course of their overall treatment.

Prof. Tit Albreht, MD

Living Well promotes scientifically validated behavioural change interventions that help cancer patients follow their treatment, enjoy a healthier lifestyle and improve their quality of life.

Mariusz Wirga, MD

Despite major advances in overall cancer treatment, many patients continue to experience significant distress. We need to offer them help before their psychological concerns reach the crisis stage, as this may negatively affect their overall recovery and response to treatment.

Christa Diegelmann, Dipl.-Psych.

About Us

We are a MedTech company that develops and brings digital solutions to market for oncology patients. Our products are ground-breaking in the field of psycho-oncology and offer comprehensive assistance during and after treatment. Psycho-oncological support is crucially important as it not only improves mental health, but also has a positive impact on the patients’ quality of life. By combining world-leading expertise in medicine and technology, our interdisciplinary team sets new standards in the industry.

phone icon

We have developed a portfolio of digital health care medical products that covers the entirety of the behavioral treatment needs of cancer patients.

microscope icon

Our clinically validated, digital health care platform will soon be prescribed by doctors and therapists in Germany as a DiGA*, and will be reimbursed by the local healthcare system.

world icon

We aim to become the #1 digital health care provider for oncology globally, and we have have a clear pathway to get there.

Our Team

Marek Ostrowski
Co-founder, Chief Executive Officer
Andrzej Jonczyk, MD
Co-founder, Chief Executive Officer for Prosoma US
Piotr Grudzinski
Co-founder, Chief Executive Officer at Prosoma GmbH
Prof. Ewa Wojtyna, MD
Chief Scientific Officer
Wojtek Bieronski
Chief Product Officer
Jakub Kuziela
Chief Financial and Operating Officer
Ema Kufel
Co-founder, Chief Business Development Officer
Ula Głowacka
Senior Product and Research Designer
Anna Anzulewicz, PhD
Head of Product Research
Meet Our Team

Trusted by healthcare organizations around the world. More partnerships to come.

Compliant with the highest standards of quality and data security

Guided by HIPAA and FDA regulations in the US
Products designed and developed in accordance with ISO 13485 [Medical Device Quality Management System]
Following the highest standards in data security and protection (ISO/IEC 27001, EU GDPR)
Ongoing DiGA submission in Germany
Class I medical device aligned with the European MDR 2017/745
DTx adoption; following the psycho-oncology standard of care for e-health in Germany (S3 Guideline)


Planned Technical Downtime: October 11, 2023

We would like to inform you that we are currently working on important updates that are necessary to further enhance the quality of our services.

See more
arrow icon

"Mental health is a prerequisite for overcoming the disease."

Germany differentiates lifestyle applications from medical applications by calling them DiGA, which is an abbreviation for Digitale Gesundheitsanwendungen,

See more
arrow icon

Daiichi Sankyo Germany demonstrates Commitment to Patient Centricity by Partnering with Prosoma

Daiichi Sankyo Germany seeks to support cancer care in a collaboration with Prosoma

See more
arrow icon
Read More News
Close Cookie Preference Manager
Cookie Settings
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts.
Strictly Necessary (Always Active)
Cookies required to enable basic website functionality.
Made by Flinch 77
Oops! Something went wrong while submitting the form.
Cookies Preferences